(EMAILWIRE.COM, September 19, 2018 ) The global 3D bioprinting market is expected to reach USD 1,332.6 Million by 2021 from USD 411.4 Million in 2016, at a CAGR of 26.5% between 2016 and 2021. On the basis of technology, the global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting. The microextrusion 3D bioprinting technology is estimated to command the largest share of the global market in 2016 due to its affordability, among other factors. The second-largest share is held by inkjet 3D bioprinting segment, due to its low cost and versatility as compared to other 3D bioprinting techniques.

3D bioprinting market Drivers :
1 Growing Demand for Organ Transplantation
2 Rise in Public and Private Funding to Support 3D Bioprinting Research Activities
3 Increasing Use of 3D Bioprinting in the Drug Discovery Process
4 Growing Focus of Market Players on 3D Bioprinting

PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=170201787

3D bioprinting market Restraints:
1 Lack of Regulatory Guidelines Governing 3D Bioprinting
2 Dearth of Trained Professionals

3D bioprinting market Opportunities:
1 Increasing Stem Cell Research
2 Growing Awareness Related to 3D Bioprinting
3 Rising Adoption of 3D Bioprinting in the Cosmetic Industry

3D bioprinting market Challenges:
1 Socio-Ethical Concerns Related to the Use of 3D Bioprinted Products
2 Limitations of Biomaterial-Based Products
3 Lack of Complete Automation

The Asia-Pacific 3D bioprinting market is expected to grow at the highest CAGR from 2016 to 2021. The key factors influencing the growth of the Asia-Pacific market are the increase in overall and stem cell research activity, growing demand for organ transplantation, and rising initiatives by market players.

Market Key Palyers:

Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), Nano3D Biosciences, Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), BioBots (U.S.), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (U.K.), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany) are some of the key players operating in the global 3D bioprinting market.

Know More: https://www.marketsandmarkets.com/Market-Reports/3d-bioprinting-market-170201787.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.